A 35-year-old woman presents with infertility. She has had dysmenorrhea, dyspareunia, and pelvic pain on defecation for 4 years. Laparoscopic examination reveals red-blue nodules on the surface of the uterus and extensive adhesions between ovaries and the fallopian tubes. Histologic examination of a biopsy from one of the nodules shows hyperplastic endometrial glands and hemorrhage in the stroma. Molecular analysis of the biopsy material reveals hypomethylation of the promoter regions of the genes that encode steroidogenic factor 1 and estrogen receptor beta. There are no mutations in the PTEN, KRAS, and MLH1 genes. Which of the following is an appropriate treatment modality in this case?